Post

Game changing: How AI and automation is revolutionising clinical trial admin 

In the wake of COVID-19, clinical trials deserve our attention more than ever. If there’s one thing to be learned …

Clinical Trials Arena Review 2023

The year 2023 has seen the first CRISPR therapy indicate it could be …

Gain Therapeutics publishes preclinical data for GM1 gangliosidosis treatment

US-based biotechnology company Gain Therapeutics has published preclinical data demonstrating the potential of small molecule allosteric regulators to treat beta-galactosidase-1 …

Bioxodes enrols first patient in Phase IIa ischemic stroke trial

Belgium-based Bioxodes has enrolled the first patient in its Phase IIa study investigating a pipeline candidate Ir-CPI for ischemic stroke. Speaking …

Valneva reports latest findings from chikungunya vaccine trial

Valneva has reported the latest positive antibody persistence data from its Study VLA1553-303 of a single dose of chikungunya vaccine, …